11/23/2020 7:36:27 AM
Amgen Provides Notice To Cytokinetics Of Termination Of Its Collaboration For Omecamtiv Mecarbil And AMG 594
10/8/2020 8:36:09 AM
Amgen, Cytokinetics And Servier Announce Topline Results From GALACTIC-HF Trial Did Not Meet Secondary Endpoint
10/2/2020 8:00:52 AM
Cytokinetics Publishes Manuscript Detailing Baseline Characteristics Of GALACTIC-HF In European Journal
9/24/2020 7:45:26 AM
Cytokinetics Announces Call For Proposals For Third Annual Communications Fellowship Program
9/17/2020 7:43:57 AM
Cytokinetics Announces GALACTIC-HF Accepted For Presentation At AHA Scientific Sessions
7/14/2020 7:39:56 AM
Cytokinetics Agrees To Series Of Transactions With RTW And Ji Xing Related To CK-3773274
5/27/2020 7:37:54 AM
Cytokinetics And ALS Association Announce Continuation Of Their Partnership In The Fight Against ALS
5/8/2020 8:32:40 AM
Amgen And Cytokinetics: FDA Grants Fast Track Designation For Omecamtiv Mecarbil In Heart Failure
4/14/2020 7:34:56 AM
Cytokinetics Says On Track To Achieve Its Key Strategic Objectives For 2020
2/26/2020 8:31:41 AM
Amgen, Cytokinetics And Servier Report Continuation Of GALACTIC-HF Following Planned Interim Analysis
1/13/2020 7:45:20 AM
Cytokinetics Now Expects Top-line Results From GALACTIC-HF In Q4 2020; Commercial Readiness Underway
1/6/2020 7:36:44 AM
Cytokinetics Says REDWOOD-HCM Has Opened To Enrollment